Lamdong Pharmaceutical Joint Stock Company reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was VND 43,470.24 million compared to VND 45,306.43 million a year ago. Net loss was VND 20,517.29 million compared to VND 5,960.65 million a year ago. Basic loss per share from continuing operations was VND 1,615 compared to VND 469 a year ago. Diluted loss per share from continuing operations was VND 1,615 compared to VND 469 a year ago.
For the six months, revenue was VND 93,082.72 million compared to VND 85,735.35 million a year ago. Net loss was VND 18,896.37 million compared to VND 10,947.47 million a year ago. Basic loss per share from continuing operations was VND 1,488 compared to VND 862 a year ago. Diluted loss per share from continuing operations was VND 1,488 compared to VND 862 a year ago.